Diseases and conditions

We have identified a number of dermatologic conditions where treatment gaps exist, and we seek to apply our revelationary science to fill these treatment gaps.

Common warts

Common warts are skin growths that can occur when a virus infects the top layer of the skin. They are often skin-colored and feel rough but can be darker and smooth. Symptoms include pain, bleeding, itching, and burning. Common warts are contagious and may interfere with social activities, cause embarrassment, and carry a social stigma.

The current treatment gap: each year over 2 million people seek treatment from health care professionals. In-office procedures are often painful or invasive, can have undesirable outcomes like scarring or dyspigmentation, and may require repeat visits. Over-the-counter topicals are marginally effective. To date, there is no FDA-approved prescription medicine available. 

Alopecia areata

Alopecia areata is an autoimmune disease that results in partial or complete loss of hair. There are a few forms of this condition, including alopecia totalis, which results in hair loss across the entire scalp, and alopecia universalis, a more advanced type that affects the entire body. Alopecia areata may be associated with serious psychological consequences, including anxiety and depression.

The current treatment gap: Up to 2% of people globally are affected at some point during their lifetime and up to 0.2% of people are affected at any given time. An injectable steroid is available but it can be painful and is not viable for long-term use.


Vitiligo is an autoimmune disease in which pigment-producing skin cells are progressively lost from the skin. As a result, areas of skin appear to be lighter on various parts of the body.

The current treatment gap: impacting 1- 2% of the global population, vitiligo is considered the most frequently occurring depigmenting disorder. Sufferers may experience reduced quality of life and psychological distress. To date, there is no FDA-approved prescription medicine available that restores pigmentation.

Androgenetic alopecia

Androgenetic alopecia is known as male pattern baldness or female pattern hair loss, it’s the most common form of hair loss.

The current treatment gap: it may affect up to 70% of men and 40% of women. Androgenetic alopecia is largely determined by genetics, though environmental factors may play a minor role. Affected individuals can be highly motivated to seek treatment, due to negative image perceptions. Currently available FDA-approved treatments can be costly and/or invasive.


Rosacea is a chronic disease characterized by enduring facial redness and/or skin thickening. Other signs of rosacea include facial flushing, visible blood vessels (telangiectasia), blemishes resembling acne (papules and pustules), and eye irritation. Burning or stinging, swelling (edema), and dry appearance may accompany these signs. Rosacea affects approximately 16 million Americans. Persistent facial redness is the single most common sign of rosacea in most skin types and, according to a survey conducted by the National Rosacea Society, affects 71% of patients with rosacea.

Seborrheic keratosis

A seborrheic keratosis is a non-cancerous skin growth affecting more than 83 million Americans and are most commonly seen in middle-aged and older adults. Seborrheic keratoses vary in color from flesh-colored to pink, yellow, gray, tan, brown, or black; can range in size from a millimeter to a few centimeters wide; and typically have a slightly elevated, waxy or scaly appearance. The number and size of seborrheic keratoses tends to increase with advancing age. Seborrheic keratoses frequently appear in highly visible locations, such as the face or neck, but can also appear anywhere on the skin, except the palms and soles.